Does Blood Work Show Alcohol Use?

Standard blood work can reveal signs of alcohol use, though what it catches depends on the type of test, how much you drank, and how recently. A routine blood panel that checks liver enzymes and blood cell size can raise suspicion of heavy or chronic drinking, but it cannot pinpoint exactly when or how much you drank. Specialized tests that look for alcohol-specific metabolites in the blood can detect drinking with far greater precision, some flagging a single episode days or even weeks later.

How Long Ethanol Itself Stays in Your Blood

The most straightforward way blood work shows alcohol use is by measuring ethanol directly. After a drink, your blood alcohol concentration (BAC) rises to a peak within roughly 30 to 60 minutes, though the speed varies by beverage. One study found that vodka with tonic produced a peak BAC averaging about 77 mg/dl within 36 minutes, while wine peaked lower (around 62 mg/dl at 54 minutes) and beer lower still (about 50 mg/dl at 62 minutes), even when all three delivered the same total amount of alcohol.¹ Spirits reach the bloodstream faster because their alcohol is more concentrated and there is less total liquid to slow gastric emptying.

Your body clears ethanol at a relatively steady rate, roughly 0.15 to 0.20 g/kg per hour for most people, though the rate increases slightly at higher concentrations.² In practical terms, that means a moderate drinker’s blood will typically show no measurable ethanol within a few hours of their last drink. If you had several drinks the night before and gave blood at a morning appointment, the ethanol itself is usually gone. This tight detection window is why direct BAC measurement is useful mainly in emergency departments and traffic stops, not for detecting a pattern of drinking over days or weeks.

Metabolites That Stick Around Longer

When your body breaks down ethanol, it produces secondary molecules that linger far longer than the alcohol itself. Two of the most clinically useful are ethyl glucuronide (EtG) and phosphatidylethanol (PEth).

EtG is a minor metabolite of ethanol that can be measured in blood plasma. In one emergency department study, nearly 40% of patients had detectable blood EtG even though only about 4% still had measurable ethanol in their system. In some cases, EtG remained detectable for more than 48 hours after the alcohol itself had been fully eliminated.³ That makes EtG a useful bridge between the very short window of direct ethanol measurement and the longer-range markers discussed below. Ethyl sulfate (EtS), another minor metabolite, follows a similar timeline and is sometimes tested alongside EtG for added reliability.⁴

PEth is the longer-range workhorse. It is a phospholipid that forms only in the presence of ethanol and embeds itself in red blood cell membranes. Because red blood cells live for about 120 days, PEth accumulates with repeated drinking and declines slowly during abstinence. A systematic review found a clear correlation between blood PEth levels and the amount of alcohol consumed over the prior two weeks.⁵ During detoxification, PEth’s half-life ranges from roughly 4 to 10 days, meaning measurable amounts can persist for several weeks after the last drink.⁶

What makes PEth especially valuable is its accuracy. In patients with alcohol use disorder and liver disease, a PEth test was 95% sensitive at detecting any drinking at all. At a higher cutoff, it was about 86% sensitive and 92% specific for heavy drinking, outperforming every traditional blood marker over both two-day and one-month timeframes.⁷ That combination of a weeks-long detection window and high accuracy is why PEth has become the go-to blood test when clinicians need to know whether someone has been drinking recently, not just whether their liver is struggling.

What Routine Liver Tests Actually Show

When people wonder whether “blood work” reveals alcohol use, they are often thinking of the liver enzyme panel included in standard metabolic tests. These enzymes do respond to alcohol, but they are blunt instruments compared to the metabolite tests above.

Gamma-glutamyl transferase (GGT) is the liver enzyme most commonly linked to drinking. One study found that alcohol drinkers had GGT levels more than three times higher than non-drinkers on average, with heavy drinkers averaging around 126 U/L versus about 25 U/L in abstainers.⁸ GGT rises in response to heavy drinking over weeks and falls during abstinence, making it a rough indicator of recent sustained drinking. But the problem is specificity: GGT can also be elevated by medications, obesity, non-alcoholic fatty liver disease, and a range of other conditions. Genetic factors further muddy the picture. A large twin study found that shared genetic influences, not alcohol exposure alone, explain a meaningful chunk of the correlation between alcohol intake and GGT levels.⁹ In other words, some people’s GGT runs higher for genetic reasons that happen to overlap with genes influencing alcohol use.

The ratio between two other liver enzymes, AST and ALT, adds another layer of information. In most liver diseases, ALT tends to be higher than AST. Alcoholic liver disease flips that pattern: AST typically exceeds ALT.¹⁰ When this AST-to-ALT ratio climbs above 2, it strongly suggests advanced alcohol-related liver damage. One study of patients with different stages of alcoholic liver disease found that about 69% of those with cirrhosis had a ratio at or above 2, while only about 8% of those with cirrhosis had a ratio at or below 1.¹¹ But this elevated ratio reflects cumulative liver damage rather than recent drinking. Someone could stop drinking entirely and still have a high AST/ALT ratio for months or years because the liver is already scarred.

Carbohydrate-deficient transferrin (CDT) sits between the liver enzymes and the direct metabolites in both specificity and clinical use. CDT rises when someone consumes substantial amounts of alcohol regularly, and it is considered a biomarker of chronic heavy intake, particularly for people drinking more than about 60 grams of ethanol per day (roughly four to five standard drinks).¹² Clinicians sometimes combine CDT and GGT, since the two markers respond to different aspects of drinking and together paint a more complete picture than either alone.¹³

Red Blood Cell Size as a Clue

One of the subtler things blood work can reveal is a change in the size of your red blood cells. Mean corpuscular volume (MCV) measures the average volume of each red cell, and chronic alcohol use tends to push this number up, a condition called macrocytosis. Alcohol appears to interfere with how bone marrow produces new red blood cells, causing them to emerge larger than normal. Because red blood cells circulate for months, MCV is slow to change and reflects a long window of exposure.

In patients with liver disease, macrocytosis was found in about 70% of alcoholics compared to roughly 23% of non-alcoholics. When MCV exceeded 100 femtoliters, it was seen in about half of the alcoholic patients but only about 3% of non-alcoholics.¹⁴ That makes a high MCV in the context of liver disease a strong pointer toward alcohol as the cause. On its own, though, MCV has fairly low sensitivity for picking up drinking in the general population. One study put its sensitivity at only about 24%, with high specificity near 96%.¹⁵ Translation: a normal MCV does not rule out heavy drinking, but a clearly elevated MCV in someone without another obvious cause (like a vitamin B12 deficiency) should prompt questions about alcohol.

Lipids, Electrolytes, and Other Metabolic Fingerprints

Heavy drinking can reshape your lipid profile in ways a physician might notice on routine blood work. Chronic excessive intake tends to push triglycerides up, largely because the liver ramps up production of large triglyceride-carrying particles.¹⁶ At the same time, alcohol tends to raise HDL (“good”) cholesterol and lower LDL cholesterol. A large study of adults undergoing annual checkups found that each additional alcoholic drink per day was associated with higher HDL and lower LDL, and that stopping drinking reversed both of those shifts.¹⁷ These lipid changes are not specific to alcohol and would not by themselves tell a doctor you have been drinking. But combined with elevated GGT and an enlarged MCV, a certain lipid pattern starts to look more suggestive.

Electrolyte disturbances are another giveaway, especially in people who drink heavily over extended periods. Chronic alcohol use is particularly hard on magnesium, potassium, and calcium levels. One case report described a patient with alcohol use disorder who arrived at the hospital with dangerously low levels of all three electrolytes at once, because magnesium depletion triggers a cascade: the body cannot properly retain potassium or activate vitamin D without adequate magnesium.¹⁸ In a study of chronic alcohol-dependent patients admitted for detox, about 30% had low phosphate and low magnesium, about 21% had low calcium, and roughly 13% had low potassium at the time of admission.¹⁹ Acute intoxication can also scramble metabolic markers: a study of adolescents with acute alcohol intoxication found that over 60% had elevated blood lactate and about 16% had outright acidosis.²⁰

Where False Positives Come From

No biomarker is perfectly specific to intentional alcohol consumption, and understanding the sources of error matters if your blood results are being used for anything consequential. Urine EtG, a closely related test to the blood version, is particularly vulnerable to false positives from incidental alcohol exposure. Mouthwash, certain medications, hand sanitizer absorbed through the skin, and even foods made with baker’s yeast have been documented as potential triggers.²¹ Blood PEth is less prone to this kind of contamination since it requires ethanol to be metabolized inside your body over a sustained period, but it is not entirely immune to confusion at very low levels.

CDT, the chronic-drinking marker, has its own false-positive issues. In patients with non-alcoholic liver diseases, about 9% produced falsely elevated CDT results, with the highest false-positive rates appearing in autoimmune hepatitis, where nearly 30% of patients tested falsely high.²² This is why clinicians rarely rely on a single marker. The standard approach is to combine several tests and consider the clinical context: a moderately elevated GGT with a normal CDT and normal MCV tells a different story than all three being abnormal at once.

When Your Body Makes Its Own Alcohol

One genuinely strange edge case deserves mention because it can produce positive alcohol blood tests in someone who has not had a drop. Auto-brewery syndrome is a rare condition in which gut microbes ferment carbohydrates into ethanol inside the body. People with this syndrome can register measurable blood alcohol after eating a carbohydrate-rich meal, without consuming any alcoholic beverages.²³ Research has identified specific bacteria, particularly certain Klebsiella species, that are unusually efficient at producing ethanol and appear to be the culprits in many documented cases.²⁴ The condition is diagnosed by checking blood alcohol after a supervised glucose challenge. It is exceedingly rare, but it has caused real problems for people facing legal or professional consequences based on blood alcohol results.

How These Tests Get Used in Practice

The setting in which blood is drawn largely determines which tests are ordered and how the results are interpreted. During a routine physical, your doctor probably checks a basic or comprehensive metabolic panel and a complete blood count. These include GGT, AST, ALT, MCV, electrolytes, and a lipid panel, but they do not automatically include PEth, EtG, or CDT. If your results show, say, a mildly elevated GGT with normal AST, a normal MCV, and unremarkable lipids, most physicians would not jump to a conclusion about alcohol. They might ask you about your drinking, or they might attribute the GGT to medication, weight, or genetics.

In clinical monitoring contexts the stakes and the tests are different. Transplant centers, for instance, increasingly rely on PEth to verify abstinence in liver transplant candidates and recipients. In one study of post-transplant patients, nearly a quarter of alcohol-dependent subjects who reported no recent drinking nonetheless had at least one positive PEth test during follow-up.²⁵ PEth’s combination of high sensitivity and a multi-week detection window has made it the preferred blood biomarker in transplant programs, substance use treatment monitoring, and some workplace testing protocols.²⁶

For forensic and legal purposes, the preanalytical handling of the blood sample matters as much as the test itself. A narrative review in a clinical chemistry journal found that, aside from maintaining a proper chain of custody, there is no strong evidence that forensic blood draws for suspected impaired driving need different collection procedures from standard clinical draws. Following established phlebotomy guidelines provides both diagnostic accuracy and forensic defensibility.²⁷

Beyond Blood

Blood is not the only specimen that can reveal drinking history. Alcohol biomarkers have been studied in hair, fingernails, meconium (a newborn’s first stool), and umbilical cord tissue. These alternative specimens can extend the detection window dramatically, sometimes capturing evidence of drinking over several months, far beyond what any blood test can show.²⁸ Fingernail EtG, for example, has been used in prenatal research to assess alcohol exposure during pregnancy.²⁹ These methods see the most use in forensic, legal, or research settings where documenting months of exposure matters more than detecting a single recent episode.

Why Genetics Complicates the Picture

How quickly your body processes alcohol and its byproducts depends partly on which gene variants you carry for the enzymes that do the work. Research in a Korean population, for example, identified specific variants in the ADH1A gene that were associated with markedly higher blood acetaldehyde concentrations, the toxic intermediate that causes flushing and nausea. Other variants in different genes were linked to lower blood alcohol levels after the same amount of drinking.³⁰ These differences mean that two people can drink the same amount and show different blood alcohol levels, different metabolite levels, and different patterns of liver enzyme elevation. For clinicians interpreting alcohol biomarkers, this genetic variability is one more reason why no single number on any single test tells the whole story. Context, consistency across multiple markers, and the patient’s clinical picture together paint a much more reliable picture than any one result on its own.